Noritsu Koki Co (TSE:7744) ROCE % : 12.35% (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Noritsu Koki Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Noritsu Koki Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.35%.

Noritsu Koki Co ROCE % Historical Data

The historical data trend for Noritsu Koki Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noritsu Koki Co ROCE % Chart

Noritsu Koki Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

6.24

5.10

0.66

3.98

2.51

Noritsu Koki Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															3.26	8.87	8.00	2.53	12.35

Noritsu Koki Co ROCE % Calculation

Noritsu Koki Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	5742	/	( ( (264141 - 46106)	+	(307257 - 67109) )	/ 2 )
	=	5742	/	( (218035	+	240148)	/ 2 )
	=	5742	/	229091.5
	=	2.51 %

Noritsu Koki Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	31072	/	( ( (279471 - 30752)	+	(285445 - 30826) )	/ 2 )
	=	31072	/	( ( 248719	+	254619 )	/ 2 )
	=	31072	/	251669
	=	12.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Noritsu Koki Co (TSE:7744) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Noritsu Koki Co ROCE % Related Terms

Thank you for viewing the detailed overview of Noritsu Koki Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Noritsu Koki Co (TSE:7744) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Noritsu Koki Co Ltd (TSE:7744) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azabu Juban 1-10-10 Joule A, 5th Floor, Minato-ku, Tokyo, JPN, 106-0045

Website

http://www.noritsu.co.jp

Noritsu Koki Co Ltd is a Japan-based company, engaged in the healthcare, drug discovery, senior life, agribusiness food, manufacturing, and other operations. In the manufacturing business, the company manufactures marking pen tip made of felt and synthetic fiber as the main product. In the healthcare business, it offers a range of medical services. In the drug discovery business, the company conducts research and development on biopharmaceuticals and regenerative medicine. The other operations of the company involves the business development and investment research, digital area business and insurance business.

Noritsu Koki Co (TSE:7744) Headlines

No Headlines